Press Releases Agilent Technologies, Inc.

Equities

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:03 2026-05-19 pm EDT			5-day change	1st Jan Change
110.57 ^USD	-1.37%		-2.06%	-18.74%

May. 19	Agilent Technologies Secures TSA Contract to Supply Airport Security Screening Systems	MT
May. 04	Agilent names Michael Buckner as chief legal officer	RE

Press Releases

May. 19	Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026	BU
May. 14	Enablement For Validity Versus Enablement For Anticipation: Lessons From Agilent Technologies, Inc. v. Synthego Corp.	AQ
May. 11	Agilent to Participate in Jefferies Global Healthcare Conference	BU
May. 04	Agilent Names Michael Buckner as Chief Legal Officer	BU
Apr. 28	Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27	BU
Apr. 15	Agilent Showcases Cancer Research Solutions at AACR 2026	BU
Apr. 13	Agilent Technologies : Partners OmixAI to Expand AI-Driven Proteomics in South Korea	PU
Apr. 01	Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader	BU
Mar. 26	Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma	BU
Mar. 20	Agilent Debuts Future of the Automated Laboratory at Korea Lab 2026	AQ
Mar. 19	Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026	BU
Mar. 11	Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States	BU
Mar. 09	Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions	BU
Feb. 25	Agilent: Fiscal Q1 Earnings Snapshot	AQ
Feb. 25	Agilent Reports First-Quarter Fiscal Year 2026 Financial Results	BU
Feb. 23	Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference	BU
Feb. 12	Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma	AQ
Feb. 11	Agilent Announces Cash Dividend of 25.5 Cents per Share	BU
Feb. 11	Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award	BU
Feb. 11	Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)	BU
Feb. 10	Agilent Technologies : Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)	PU
Feb. 04	Agilent Showcases Next‑Generation Automated Solutions at SLAS2026	BU
Feb. 03	Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio	PU
Feb. 02	Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25	BU
Jan. 23	Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System	BU